<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GRIK1 - Glutamate Receptor Kainate Type Subunit 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>GRIK1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Glutamate Ionotropic Receptor Kainate Type Subunit 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>21q21.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>2899</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000196517</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>138245</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P39086</td>
</tr>
<tr>
<td class="label">Assoc
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GRIK1 - Glutamate Receptor Kainate Type Subunit 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>GRIK1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Glutamate Ionotropic Receptor Kainate Type Subunit 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>21q21.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>2899</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000196517</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>138245</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P39086</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autism" style="color:#ef9a9a">Autism</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>
Grik1 Glutamate Receptor Kainate Type Subunit 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The ionotropic glutamate receptors are ligand-gated ion channels that mediate the majority of excitatory synaptic transmission in the central nervous system. Kainate receptors, named after their ability to be activated by the agonist kainic acid, represent a subclass of ionotropic glutamate receptors that play important roles in synaptic plasticity, neuronal excitability, and various neurological conditions. [@gene]
This gene encodes a subunit of the kainate receptor family, which is differentially expressed throughout the brain and contributes to the complex regulation of glutamatergic signaling. [@additional]
GRIK1 (Glutamate Ionotropic Receptor Kainate Type Subunit 1) encodes the glutamate receptor 5 (GluR5) subunit of the kainate-type glutamate receptors. Kainate receptors play important roles in synaptic transmission and plasticity throughout the central nervous system. [@jane2009]
GRIK1 encodes the GluR5 protein (also known as GRIK1), a subunit of the kainate glutamate receptor family.
Kainate receptors are ionotropic glutamate receptors that mediate excitatory synaptic transmission. The GRIK1 subunit (GluR5) contributes to:
GRIK1 is expressed throughout the brain with highest expression in:
The study of Grik1 Glutamate Receptor Kainate Type Subunit 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
GRIK1 exhibits a heterogeneous expression pattern across the brain with highest levels in the cerebellum, hippocampus, and cerebral cortex. In the cerebellum, GRIK1 is predominantly expressed in Purkinje cells and granule cells, where it contributes to synaptic plasticity and motor learning. The hippocampus shows moderate expression in CA3 pyramidal neurons and dentate gyrus granule cells, regions critical for memory formation and pattern separation.
During development, GRIK1 expression follows a temporal pattern with higher expression levels in embryonic and early postnatal stages, gradually decreasing to adult levels. This developmental regulation suggests important roles in neuronal circuit formation and synaptic pruning during critical periods of brain development.
GRIK1 forms functional kainate receptors that can exist as homomers or heteromers with other GRIK subunits (GRIK2, GRIK3, GRIK4, GRIK5). These receptors are ligand-gated ion channels that permeate Na⁺ and K⁺ ions, with some subunit compositions also permitting Ca²⁺ influx. The receptor activation leads to depolarization and excitation of neurons.
Kainate receptors, including those containing GRIK1, play complex roles in synaptic transmission. They can act as postsynaptic receptors mediating excitatory responses, as well as presynaptic receptors modulating neurotransmitter release. The receptors exhibit diverse pharmacological profiles depending on their subunit composition.
Research has implicated GRIK1 in Alzheimer's disease pathophysiology. Studies have shown altered expression of GRIK1 in AD brains, particularly in regions affected by amyloid pathology. The kainate receptor system may interact with amyloid-beta to modulate synaptic dysfunction and excitotoxicity in AD.
GRIK1 mutations have been associated with epileptic encephalopathies. Loss-of-function variants can lead to dysregulated glutamatergic signaling and increased neuronal excitability. Animal models lacking GRIK1 show increased susceptibility to seizures.
Genetic studies have identified GRIK1 variants in some individuals with autism spectrum disorder. The role of kainate receptors in synaptic development and function provides a plausible mechanism for this association.
While primarily studied in the nervous system, GRIK1 expression has been detected in some cancer cell lines, where it may contribute to tumor cell proliferation and migration in certain contexts.
Targeting GRIK1 for therapeutic intervention presents challenges due to the complex pharmacology of kainate receptors. Several approaches are under investigation:
GRIK1 knockout mice have been generated and characterized. These mice exhibit:
[@lerma2001]: Lerma J, et al. (2001).
[@jane2009]: Jane DE, et al. (2009). "Kainate receptor agonists and antagonists." Pharmacology & Therapeutics 121(3): 294-307.
[^5
The following diagram shows the key molecular relationships involving GRIK1 - Glutamate Receptor Kainate Type Subunit 1 discovered through SciDEX knowledge graph analysis: